ArticleMolecular cancer2010

A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.

Paolo Fardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.